CD44 and neoplasm: Emerging studies show that CD44 is an important biomarker of a cellular subpopulation (cancer stem cells, CSCs), which are capable of self-renewal and have the capacity for initiation, progression, invasion, metastasis, tumor recurrence, and resistance to chemo- and radiotherapy [7].